We have no financial relationship with Muddy Waters Research LLC, St. Jude Medical, or MedSec Ltd. We plan to release a peer-reviewed report shortly so that the greater community may analyze our findings and results.
Topics: Medical Device Security, Clinical Engineering, Healthcare IT, Medical Device Risk Assessments, Medical Device Risk Scoring, Shadow IT, Vulnerability Scanning, Clinical Databases, Asset Discovery
Ann Arbor, MI, March 25, 2016 — Healthcare security company Virta Laboratories, Inc. received a $750K grant from the NSF Small Business Innovation Research (SBIR) program. Virta Labs provides solutions for hospitals and medical device manufacturers to measure and visualize exposure to cybersecurity risks without interrupting clinical workflow. The company plans to use the federal grant to extend its product lines into healthcare delivery organizations that face serious cybersecurity challenges. Virta Labs received a Phase I grant from the same program in 2015.
People have been asking us all week for our opinions on the FDA's new postmarket cybersecurity draft guidance. All three of Virta Labs' founders have been active in this area, with extensive research in applied security and longstanding support for collaborative efforts:
- raising the flag on potential issues in 2008;
- demonstrating the first attacks on a medical implant;
- signal-injection attacks in the analog domain;
- building novel nonintrusive defenses;
- organizing a series of successful workshops to bring together stakeholders for constructive discussions;
- conducting meta-analysis of postmarket security monitoring; and
- educating the National Academy of Engineering and numerous government bodies about the risks and rewards of medical device security
We read the draft guidance so that you could tl;dr and get back to your own job. Here are the highlights, as we see them.